All In Biotech

Drug Trial Radar · NCT01406678

Remote Ischemic Preconditioning in Coronary Artery Bypass Grafting With Cold Crystalloid Cardioplegic Arrest

Effect of Remote Ischemic Preconditioning in Patients Undergoing On-pump Coronary Artery Bypass Graft Surgery With Crystalloid Cardioplegic Arrest

Last checked: Nov 20, 2026Latest source record: May 10, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,204 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,204

Actual

Start

Jul 2008

Primary completion

Mar 2018

Study completion Apr 2020

Sponsor

Lead sponsor
University Hospital, EssenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 1, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Remote ischemic preconditioning (RIPC) with transient upper limb ischemia/reperfusion reduces myocardial injury in patients undergoing on-pump coronary artery bypass (CABG) surgery with cross-clamp fibrillation or blood cardioplegia for myocardial protection. The present study assesses protection of heart, brain and kidney by RIPC under crystalloid cardioplegic arrest. The study also addresses safety and clinical outcome.

Conditions

  • Myocardial Injury

Interventions

  • RIPCProcedure

    3 cycles of 5 min left upper arm ischemia by inflation of a blood pressure cuff to 200 mmHg and 5 min reperfusion

  • ControlProcedure

    Coronary artery bypass surgery without remote ischemic preconditioning protocol

  • isoflurane+sufentanil anesthesiaDrug

    Anaesthesia is maintained by inhaled isoflurane in concentrations 0.7-0.8 % end-tidal with additional sufentanil injected during surgery, as required. During extracorporal circulation patients receive isoflurane via a vaporizer incorporated in the extracorporeal gas supply in the same concentrations.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Perioperative extent of myocardial injury as measured by cardiac troponin I serum release over 72 hours after CABG surgery and its area under the curve (AUC).Time frame: 72 hours postoperatively after CABG surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Department of Thoracic and Cardiovascular Surgery, West-German Heart Center, University Duisburg-Essen

    Essen, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.